CNCR vs. URNM

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and URNM (NorthShore Global Uranium Mining ETF) are both exchange-traded funds - CNCR is a Health & Biotech Equities fund tracking the Loncar Cancer Immunotherapy Index, while URNM is a Commodity Producers Equities fund tracking the North Shore Global Uranium Mining Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.85%/yr for URNM.

Performance

CNCR vs. URNM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and NorthShore Global Uranium Mining ETF (URNM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

URNM

• 1D: 6.87%
• 1M: -2.67%
• YTD: 19.04%
• 6M: 20.65%
• 1Y: 71.15%
• 3Y*: 29.62%
• 5Y*: 17.52%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. URNM - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
URNM NorthShore Global Uranium Mining ETF	-4.75%

CNCR vs. URNM - Sectors Allocation Comparison

Sectors	CNCR	URNM
Healthcare	96.6%	-
Financial Services	3.3%	-
Basic Materials	-	2.6%
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	97.4%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CNCR vs. URNM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

URNM

URNM Risk / Return Rank: 38
URNM Sharpe Ratio Rank: 39
URNM Sortino Ratio Rank: 39
URNM Omega Ratio Rank: 36
URNM Calmar Ratio Rank: 43
URNM Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. URNM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and NorthShore Global Uranium Mining ETF (URNM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNCR	URNM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.39	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.37	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.70	—

Drawdowns

CNCR vs. URNM - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum URNM drawdown of -50.78%. Use the drawdown chart below to compare losses from any high point for CNCR and URNM.

Drawdown Indicators

	CNCR	URNM	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-50.78%	+50.78%
Max Drawdown (1Y) Largest decline over 1 year	—	-32.04%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-50.78%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-50.78%	—
Current Drawdown Current decline from peak	0.00%	-22.21%	+22.21%
Average Drawdown Average peak-to-trough decline	0.00%	-18.02%	+18.02%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	14.61%	—

Volatility

Volatility by Period

	CNCR	URNM	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	15.06%	—
Volatility (6M) Calculated over the trailing 6-month period	—	39.86%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	51.36%	-51.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	48.23%	-48.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	46.85%	-46.85%

CNCR vs. URNM - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is lower than URNM's 0.85% expense ratio.

Dividends

CNCR vs. URNM - Dividend Comparison

CNCR has not paid dividends to shareholders, while URNM's dividend yield for the trailing twelve months is around 2.67%.

Position	TTM	2025	2024	2023	2022	2021	2020
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
URNM NorthShore Global Uranium Mining ETF	2.67%	3.18%	3.18%	3.63%	0.00%	6.70%	2.57%

Frequently Asked Questions

Which ETF is better, CNCR or URNM?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or URNM?

CNCR is cheaper with a 0.79% expense ratio, compared with 0.85% for URNM.

Which ETF pays a higher dividend yield, CNCR or URNM?

URNM has the higher dividend yield at 2.67%, compared with 0.00% for CNCR.

What is the main difference between CNCR and URNM?

CNCR is categorized as Health & Biotech Equities, while URNM is Commodity Producers Equities. CNCR tracks Loncar Cancer Immunotherapy Index, while URNM tracks North Shore Global Uranium Mining Index. Their fees differ too: 0.79% for CNCR and 0.85% for URNM.